The US Senate's Health, Education, Labor and Pensions Committee has confirmed Margaret Hamburg, President Barack Obama's nominee for FDA Commissioner, as was generally expected. The hearing was moved forward one week, according to the New York Times, because of the increase in cases of H1N1 influenza in the USA. Ms Hamburg fielded questions about the federal government's response to the disease.
The minority Republicans on the Committee might have been tempted to delay matters, in retaliation for Democratic stalling against previous nominees in the administration of George W Bush (Marketletters passim). However, the NYT suggested that demoting to Deputy Commissioner the acting Commissioner, Joshua Sharstein, a former staffer of Representative Henry Waxman (Democrat, California), as well as previously an employee of drug industry critic the Public Citizen, would make more tactical sense. The CQ Today newsletter also reported that Republicans were concerned about legislation that would give the FDA authority to regulate tobacco products.
Ms Hamburg's nomination must be confirmed by the full Senate, which is not expected to pose any difficulties if Democrats remain united. With the defection of former Republican Arlen Spector (Pennsylvania) this month, there is now a 60-40 majority, which makes partisan filibustering impossible and also has consequences for the passage of legislation.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze